Cargando…

Precision Medicine in COVID-19: IL-1β a Potential Target

Detalles Bibliográficos
Autores principales:	Parisi, Valentina, Leosco, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	To The Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166005/ https://www.ncbi.nlm.nih.gov/pubmed/32313848 http://dx.doi.org/10.1016/j.jacbts.2020.04.006

Ejemplares similares

COVID-19: Precision Medicine and Vascular Endothelium
por: Tricarico, Gerardo, et al.
Publicado: (2021)

Epicardial Adipose Tissue-Derived IL-1β Triggers Postoperative Atrial Fibrillation
por: Cabaro, Serena, et al.
Publicado: (2022)

The role of IL-35 and IL-37 in breast cancer – potential therapeutic targets for precision medicine
por: Ma, Yuntao, et al.
Publicado: (2022)

In reply—COVID-19: Precision Medicine and Vascular Endothelium
por: Cresci, Sharon, et al.
Publicado: (2021)

IL-33 and the Cytokine Storm in COVID-19: From a Potential Immunological Relationship towards Precision Medicine
por: Furci, Fabiana, et al.
Publicado: (2022)

Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
por: Campana, Pasquale, et al.
Publicado: (2020)

Precision medicine in colorectal cancer
por: Aziz, Mohammad Azhar
Publicado: (2019)

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
por: Caminati, Marco, et al.
Publicado: (2023)

Effects of exercise training on cardiovascular adrenergic system
por: Leosco, Dario, et al.
Publicado: (2013)

Precision medicine for corticotherapy in COVID-19
por: Annane, Djillali, et al.
Publicado: (2022)

Serum IL-1β and IL-18 correlate with ESR and CRP in multidrug-resistant tuberculosis patients
por: Wang, Yanli, et al.
Publicado: (2015)

Epicardial Adipose Tissue and IL-13 Response to Myocardial Injury Drives Left Ventricular Remodeling After ST Elevation Myocardial Infarction
por: Parisi, Valentina, et al.
Publicado: (2020)

Airway IL-1β associates with IL-5 production following dust mite allergen inhalation in humans
por: Burbank, Allison J., et al.
Publicado: (2021)

Will the Precision Medicine Initiative Transform Cardiovascular Translational Research?
por: Mann, Douglas L., et al.
Publicado: (2016)

The elderly at risk: aldosterone as modulator of the immune response to SARS-CoV-2 infection
por: Campana, Pasquale, et al.
Publicado: (2021)

Pharmacological targeting of HMGB-1 translocation: A potential therapeutic strategy for COVID-19
por: Bagheri, Vahid
Publicado: (2022)

TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD
por: Furci, Fabiana, et al.
Publicado: (2023)

Cost of precision medicine at a referral center for cystic fibrosis
por: Marson, Fernando Augusto Lima
Publicado: (2020)

Red Flags, Prognostic Impact, and Management of Patients With Cardiac Amyloidosis and Aortic Valve Stenosis: A Systematic Review and Meta-Analysis
por: Myasoedova, Veronika A., et al.
Publicado: (2022)

Is precision medicine relevant in the age of COVID-19?
por: Zhou, Amy, et al.
Publicado: (2021)

Interleukin-17: A potential therapeutic target in COVID-19
por: Mendoza, Vicky M. Montaño
Publicado: (2020)

Future therapies for pancreatic carcinoma: Insights into cancer precision medicine
por: Jiang, Qiu-Yu, et al.
Publicado: (2022)

Comment on “Designing Robust N-of-1 Studies for Precision Medicine: Simulation Study and Design Recommendations”
por: Landes, Reid D
Publicado: (2020)

A CRISPR/CAS9‐based strategy targets the personalized chimeric neosequence in fusion‐driven cancer genome for precision medicine
por: Huang, Wei, et al.
Publicado: (2021)

Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC
por: Mann, JE, et al.
Publicado: (2017)

In Situ Immune Profiling Identifies Immune Players Involved in Allograft Rejection: A Call for Precision Medicine
por: Napoli, Claudio, et al.
Publicado: (2020)

Targeting IL-1β in the Treatment of Atherosclerosis
por: Mai, Wuqian, et al.
Publicado: (2020)

The R156H variation in IL-12Rβ1 is not a mutation
por: van de Vosse, Esther, et al.
Publicado: (2013)

Precision therapeutic targets for COVID-19
por: Krumm, Zachary A., et al.
Publicado: (2021)

Systems Medicine for Precise Targeting of Glioblastoma
por: Zeng, Jie, et al.
Publicado: (2023)

Personal protective equipment in Covid-19: Evidence-based quality and analysis of YouTube videos after one year of pandemic
por: Gerundo, Gerardo, et al.
Publicado: (2022)

Historical root of precision medicine: an ancient concept concordant with the modern pharmacotherapy
por: Moeini, Reihaneh, et al.
Publicado: (2017)

Potential of multiomics technology in precision medicine
por: Putignani, Lorenza, et al.
Publicado: (2019)

Gender Disparity in Cardiovascular Disease in the Era of Precision Medicine
por: Hosseini, Naeimeh, et al.
Publicado: (2023)

Reply: In Situ Immune Profiling Identifies Immune Players Involved in Allograft Rejection: A Call for Precision Medicine
por: Peyster, Eliot G., et al.
Publicado: (2020)

The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?
por: Wang, Xiaofang, et al.
Publicado: (2021)

Towards precision medicine: Omics approach for COVID-19
por: Cen, Xiaoping, et al.
Publicado: (2023)

Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19
por: Bell, Lucy CK, et al.
Publicado: (2020)

Transcriptional response modules characterize IL-1β and IL-6 activity in COVID-19
por: Bell, Lucy C.K., et al.
Publicado: (2020)

The role of inflammation and metabolic risk factors in the pathogenesis of calcific aortic valve stenosis
por: Conte, Maddalena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_agr5aeb87s0b4pel7kvad6a5n3